Sun Pharmaceutical Industries Limited has announced its schedule for upcoming analyst and institutional investor meetings. These meetings are set to take place in February 2026. The company will engage in group and one-on-one interactions with various financial entities. The schedule includes the Nuvama India Conference 2026 in Mumbai on February 9, 2026. This will be followed by the MANTHAN - Systematix India Annual Conference on February 10, 2026, also in Mumbai. On February 11, 2026, Sun Pharma will attend Axis Capital's Flagship India Conference in Mumbai. Further engagements include Kotak Securities Limited's CHASING GROWTH 2026 on February 23, 2026, and IIFL's 17th Enterprising India Global Investors' Conference on February 24, 2026, both in Mumbai. Sun Pharma has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings. The company also noted that the schedule is subject to change due to unforeseen circumstances.
